SCHEMBL2990688

SCHEMBL2990688

CC(O)c1cc(O)c(O)c(O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.50
GABRB2 P47870 1/20 0.50
SELL P14151 1/20 0.46
SELP P16109 1/20 0.46
SELE P16581 1/20 0.46
ADRB2 P07550 2/20 0.42
ADRB1 P08588 2/20 0.42
ADRB3 P13945 2/20 0.42
HKDC1 Q2TB90 1/20 0.42
TDP1 Q9NUW8 5/20 0.40
KDM4E B2RXH2 5/20 0.40
RECQL P46063 4/20 0.40
MAPT P10636 4/20 0.40
LMNA P02545 3/20 0.40
TSHR P16473 2/20 0.40
NFKB1 P19838 2/20 0.40
HIF1A Q16665 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MTOR P42345 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25886915 0.80 GABRA1 (0.52) GABRA1GABRB2SELLSELPSELE
SCHEMBL6346880 0.80 GABRA1 (0.73) GABRA1GABRB2SELLSELPSELE
SCHEMBL31500497 0.79 TDP1 (0.38) GABRA1GABRB2ADRB2ADRB1ADRB3
SCHEMBL9334010 0.78 UGT2B7 (0.46) TDP1KDM4ERECQLMAPTLMNA
SCHEMBL9331671 0.78 UGT2B7 (0.46) TDP1KDM4ERECQLMAPTLMNA
SCHEMBL9331613 0.78 UGT2B7 (0.46) TDP1KDM4ERECQLMAPTLMNA
SCHEMBL18558876 0.77 SELL (0.43) GABRA1GABRB2SELLSELPSELE
SCHEMBL22991576 0.76 CA1 (0.50) GABRA1GABRB2KDM4EMAPTLMNA
SCHEMBL29525823 0.76 TDP1 (0.65) ADRB2ADRB1ADRB3TDP1KDM4E
SCHEMBL9812409 0.76 CA1 (0.44) GABRA1GABRB2ADRB1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120136703-A Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound 三菱瓦斯化学株式会社 2025-06-13 CN disclosed
CN-120136704-A Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound 三菱瓦斯化学株式会社 2025-06-13 CN disclosed
US-20220348698-A1 COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND, AS WELL AS METHOD FOR PRODUCING IODINE-CONTAINING VINYL POLYMER AND ACETYLATED DERIVATIVE THEREOF MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-11-03 US disclosed
US-7777073-B2 Topical delivery system for antiaging and skin whitening agents BIODERM RESEARCH (US) 2010-08-17 US disclosed
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents BIODERM RESEARCH (US) 2009-03-19 US disclosed
CN-1131086-A Branched polycarbonate preforms, blow moldable polycarbonates, and method for making GEN ELECTRIC (US) 1996-09-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents TYR, MMP17, MMP1 GABRA1 4083/4885GABRB2 3279/4885SELL 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.